QR Code

Progression-directed ablative radiotherapy improves event-free survival in oligoprogressive NSCLC

IntroductionTo assess the efficacy of progression-directed radiation therapy (PDRT) in patients with oligoprogressive non-small cell lung cancer (NSCLC), with particular focus on disease progression and changes in systemic therapy.Materials and methodsFrom January 2020 to October 2025, a retrospecti...

Description complète

Enregistré dans:
Auteurs principaux: Lorenzo De Sanctis, Riccardo Ray Colciago, Giulia Rossano, Matteo Ferrari, Matteo Mombelli, Ilenia Manno, Federica Ferrario, Sara Saufi, Valeria Faccenda, Denis Panizza, Gaia Passarella, Stefania Canova, Diego Luigi Cortinovis, Stefano Arcangeli
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2026-05-01
Collection:Frontiers in Oncology
Sujets:
event-free survival
local control
oligoprogressive non-small cell lung cancer
progression-directed radiation therapy
systemic therapy
Accès en ligne:https://www.frontiersin.org/articles/10.3389/fonc.2026.1766544/full
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires